Predictive molecular profiling in blood of healthy vasospastic individuals: Clue to targeted prevention as personalised medicine to effective costs

44Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Paradigm change from late interventional approach to predictive diagnostics followed by targeted prevention before manifest pathology, presents innovative concept for advanced healthcare. Preselection of healthy but pathology-predisposed individuals is the primary task in the overall action. Vasospasm is a frequent syndrome defined as an inappropriate constriction or insufficient dilatation in microcirculation. Vasospastic individuals are considered as healthy subpopulation predisposed to several pathologies including neurodegeneration. Clinical observations, subcellular imaging and "gene hunting"-investigations provide evidence for vasospasm as predisposition to glaucoma; development of further related pathologies cannot be excluded. Predictive molecular-profiling in blood can specify individual predisposition for effective prevention. © 2010 European Association for Predictive, Preventive and Personalised Medicine.

Cite

CITATION STYLE

APA

Yeghiazaryan, K., Flammer, J., & Golubnitschaja, O. (2010, June). Predictive molecular profiling in blood of healthy vasospastic individuals: Clue to targeted prevention as personalised medicine to effective costs. EPMA Journal. https://doi.org/10.1007/s13167-010-0032-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free